These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2018-001441-14 PEMBROLIZUMAB IN MMR-PROFICIENT METASTATIC COLORECTAL CANCER PHARMACOLOGICALLY PRIMED TO TRIGGER DYNAMIC HYPERMUTATION STATUS PEMBROLIZUMAB IN PAZIENTI CON CANCRO DEL COLON RETTO METASTATICO CON SI... not-yet-due
Other 2019-002074-32 POST-SURGICAL LIQUID BIOPSY-GUIDED TREATMENT OF STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS TRATAMIENTO POSTQUIRÚRGICO GUIADO POR BIOPSIA LÍQUIDA DE PACIENTES CON CÁNCER DE COLON EN ESTA... not-yet-due
Other 2022-001669-11 Restoring sensitivity to immunotherapy in advanced triple negative breast cancer exploiting Ceralasertib priming followed by combined Durvalumab/Nab-paclitaxel: The ATRiBRAVE Trial. Ripristinare la... not-yet-due